HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Boostrix (GlaxoSmithKline).

Abstract
GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster immunization against diphtheria, tetanus and pertussis (DTPa) infections.
AuthorsTaff Jones
JournalIDrugs : the investigational drugs journal (IDrugs) Vol. 8 Issue 8 Pg. 656-61 (Aug 2005) ISSN: 1369-7056 [Print] England
PMID16044375 (Publication Type: Journal Article)
Chemical References
  • Boostrix
  • Diphtheria-Tetanus-Pertussis Vaccine
Topics
  • Adolescent
  • Adult
  • Child
  • Diphtheria-Tetanus-Pertussis Vaccine (chemistry, immunology, pharmacokinetics, toxicity)
  • Humans
  • Immunization, Secondary
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: